PURPOSE: To investigate whether @entity910 ( @entity910 ) for @entity5 of the liver in central location is a sufficient and safe therapeutic option. MATERIAL AND METHODS: According to predefined criteria, 23 of 136 @entity1 were chosen to be treated with @entity910 because of @entity96 . At the time of the first @entity910 , the @entity1 had 28 central @entity5 (27 metastases, one HCC), which were treated in 34 sessions with 64 laser applications and had a clinical and imaging follow-up every 3 months. RESULTS: The primary effectiveness rate was 74.1% and the secondary effectiveness rate 82.1%. The mortality rate was 0%. Major complications occurred in one @entity1 ( @entity1143 ), while minor complications occurred in 10 @entity1 . During the median follow-up of 20 months (range 3-57 months), @entity5 progression developed in 22% of the @entity5 . The effectiveness rate was 78.6%, 71.4% and 64.3% after 3, 6 and 9 months. The median survival was 46.0 months (95% confidence interval: 28.6-47.1 months). CONCLUSION: In our @entity1 , complications and ablation rate of @entity910 for central @entity96 do not differ from those in peripheral location as described in the literature.

[Laser-induced thermotherapy ( @entity910 ) of XXXX of the liver in central location: results and complications].

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity1143 :: ('MESH:D010996', 'Disease') :: ['hemorrhagic pleural effusion'] @entity96 :: ('MESH:D008113', 'Disease') :: ['malignant liver tumors', 'liver tumors'] @entity5 :: ('MESH:D009369', 'Disease') :: ['local tumor', 'tumors'] @entity910 :: ('MESH:D004409', 'Disease') :: ['laser-induced thermotherapy', 'LITT']
@entity5 :: (MESH:D009369,Disease) :: ['tumors']
